Anorexigenic peptide (leptin, obestatin, nesfatin-1) levels and their impact on assisted reproductive technology treatment outcomes in patients with polycystic ovary syndrome.

Varli, Bulut; Sükür, Yavuz Emre; Özmen, Batuhan; Ergüder, Berrin Imge; Sönmezer, Murat; Berker, Bülent; Atabekoglu, Cem; Aytaç, Rusen

Varli, Bulut; Sükür, Yavuz Emre; Özmen, Batuhan; Ergüder, Berrin Imge; Sönmezer, Murat; Berker, Bülent; Atabekoglu, Cem; Aytaç, Rusen.

Afiliação

Varli B; Department of Obstetrics and Gynecology, Faculty of Medicine, Ankara University, Ankara, Turkey.
Sükür YE; Department of Obstetrics and Gynecology, Faculty of Medicine, Ankara University, Ankara, Turkey.
Özmen B; Department of Obstetrics and Gynecology, Faculty of Medicine, Ankara University, Ankara, Turkey.
Ergüder BI; Department of Biochemistry, Faculty of Medicine, Ankara University, Ankara, Turkey.
Sönmezer M; Department of Obstetrics and Gynecology, Faculty of Medicine, Ankara University, Ankara, Turkey.
Berker B; Department of Obstetrics and Gynecology, Faculty of Medicine, Ankara University, Ankara, Turkey.
Atabekoglu C; Department of Obstetrics and Gynecology, Faculty of Medicine, Ankara University, Ankara, Turkey.
Aytaç R; Department of Obstetrics and Gynecology, Faculty of Medicine, Ankara University, Ankara, Turkey.

Clin Exp Reprod Med ; 48(4): 368-373, 2021 Dec.

Article em En | MEDLINE | ID: mdl-34875744